OUR PRODUCTS

Shaping the Future of Regenerative Solutions

Regenerative Research Group provides premium biologics derived from postnatal tissues, processed in accordance with FDA regulations. We empower healthcare providers with innovative biological solutions designed to support regenerative research and advance patient care.

Schedule a Call Partner with Us

EXM

Extracellular Matrix

Available in DMSO or Glycerol

EXM is a placental tissue extracellular matrix allograft. It is a minimally manipulated human tissue flowable allograft, processed to retain its structural properties for homologous use, as determined by a healthcare provider.

Partner with Us

EXO

Exosome Vesicle

with Growth Factors

EXO is a biologic product containing processed nanovesicles, derived from extracellular vesicles, designed to preserve their natural properties and components. These biologic products are developed to meet high standards of quality and safety for research and clinical applications.

Partner with Us

Proprietary Cryopreservation Processing

These products are processed following strict quality and safety protocols designed to reduce potential contaminants or harmful components. Additionally, processing methods are intended to preserve the relevant biological characteristics of the materials.

Our EXM Product meets FDA criteria to be regulated as a 361 HCT/P.

Minimal Manipulation
The product is not significantly altered from its original form during the processing phase.

Homologous Use
It is used for the same/similar function in the recipient as in the donor, such as cushioning or structural support.

Not Combined with Other Substances
It is not mixed with drugs, biologics, or other non-tissue components.

No Systemic Effect / Does Not Depend on Metabolic Activity
It does not rely on systemic action.